BioAtla (BCAB)
(Delayed Data from NSDQ)
$1.51 USD
-0.01 (-0.33%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.50 -0.01 (-0.66%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: -- |
6/2024 | $-0.45 | 0.00% |
Earnings Summary
For their last quarter, BioAtla (BCAB) reported earnings of -$0.48 per share, beating the Zacks Consensus Estimate of $-0.57 per share. This reflects a positive earnings surprise of 15.79%. Look out for BCAB's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting a year-over-year increase of 40%.
Earnings History
Price & Consensus
Zacks News for BCAB
Can BioAtla, Inc. (BCAB) Climb 260% to Reach the Level Wall Street Analysts Expect?
BCAB: What are Zacks experts saying now?
Zacks Private Portfolio Services